- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01095276
Impact of Nebulized Dornase Alpha on Mechanically Ventilated Patients
Inhaled Dnase (Pulmozyme®) as a Non-Invasive Treatment of Atelectasis in Mechanically Ventilated Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Lobar or segmental collapse of the lung in mechanically ventilated patients is a relatively common occurrence in the Intensive Care Unit. Available treatments are either labor or time intensive and not highly effective.
Methods: We conducted a randomized, placebo-controlled, double-blind pilot study to determine whether nebulized recombinant human dornase alpha (Pulmozyme, Genentech) improves radiologic and clinical outcomes in ventilated patients with lobar atelectasis. Outcomes of interest were chest radiograph score, oxygenation, lung compliance, and rate of extubation over the first 5 days. The groups consisted of 14 intervention patients and 16 control patients. They were similar with respect to basic demographics, age, gender, and use of therapeutic modalities relating to lung function. Baseline average chest x-ray scores, Pa02/FI02 ratios, and static compliance were not significantly different. Analysis was limited to the first 5 days.
Results: There was a significant improvement in oxygenation for the intervention group at day 5 (p=0.03). There were no significant differences in chest radiograph score, compliance, or rate of extubation. Two patients died in the intervention group, whereas none died in the control group (NS).
Conclusions: These pilot data suggest that inhaled dornase alpha appears to be safe and is associated with improved oxygenation 5 days after initiation of therapy in mechanically ventilated patients compared to placebo. Larger studies are needed to confirm these findings and determine if this intervention decreases ICU morbidity and mortality.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Jersey
-
Newark, New Jersey, United States, 07183
- University of Medicine and Dentistry of New Jersey
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- current ventilator use
- onset of lobar or whole lung collapse over the previous 12 hours
- age greater than 18
Exclusion Criteria:
- quadriplegia or debilitating neuromuscular condition
- chronic ventilator dependence
- pneumothorax
- frank hemoptysis
- elevated intracranial pressure
- intracranial bleed
- pregnancy or active nursing
- concurrent use of other investigational drugs
- history of allergy to Pulmozyme®, Chinese Hamster Ovary-derived biologics, or any of the components of the active or placebo formulations.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Nebulized saline
patients on mechanical ventilation who were randomized to receive a placebo comparator (vehicle solution for dornase alpha)
|
Saline packaged identically to the dornase alpha intervention unit doses and coded for blinding by the company providing the intervention drug (dornase alpha).
|
Active Comparator: dornase alpha
patients on mechanical ventilation who were randomly assigned to receive dornase alpha by in-line nebulization
|
nebulized dornase alpha: 2.5 mg by in-line nebulizer BID
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total Chest X Ray Score
Time Frame: Days 0-30
|
Days 0-30
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Oxygenation (Pa02/FI02)
Time Frame: Days 0-30
|
Days 0-30
|
Static Lung Compliance
Time Frame: Days 0-30
|
Days 0-30
|
Time to Extubation
Time Frame: Days 0-30
|
Days 0-30
|
Collaborators and Investigators
Investigators
- Principal Investigator: Jessica N Zitter, MD, MPH, UMDNJ, Department of Medicine
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0120030304
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Atelectasis
-
Seoul National University HospitalCompletedPulmonary Atelectasis, Postoperative | Atelectasis, CompressionKorea, Republic of
-
Seoul National University HospitalCompletedAtelectasis, Postoperative PulmonaryKorea, Republic of
-
Kasr El Aini HospitalCairo UniversityCompletedAnesthesia Induced AtelectasisEgypt
-
The Third Xiangya Hospital of Central South UniversityXiangya Hospital of Central South UniversityCompletedPostoperative Pulmonary AtelectasisChina
-
Menoufia UniversityNot yet recruitingAtelectasis, Postoperative
-
Xuzhou Medical UniversityCompleted
-
Severance HospitalCompletedAtelectasis, PostoperativeKorea, Republic of
-
Emory UniversityPEEP Medical, LLCCompletedPostoperative AtelectasisUnited States
-
Mansoura UniversityEnrolling by invitationAnesthesia Induced AtelectasisEgypt
-
Dokuz Eylul UniversityNot yet recruitingAtelectasis, Postoperative Pulmonary
Clinical Trials on Saline
-
Vanderbilt University Medical CenterActive, not recruitingPostural Tachycardia SyndromeUnited States
-
Johns Hopkins UniversityCystic Fibrosis FoundationCompletedCystic Fibrosis
-
University Hospital Inselspital, BerneCompletedCardiovascular Diseases | Valvular Heart DiseaseSwitzerland
-
Aalborg UniversityThe Danish Rheumatism AssociationCompleted
-
Imam Abdulrahman Bin Faisal UniversityUnknownOtorhinolaryngologic Diseases | RhinosinusitisSaudi Arabia
-
Dr. Michael FlavinWithdrawn
-
Szpital im. Św. Jadwigi ŚląskiejRecruiting
-
Makassed General HospitalCompletedLength of Hospital StayLebanon
-
University of Washington, the Collaborative Health...Cystic Fibrosis FoundationCompleted
-
Qassim UniversityCompletedApical Periodontitis | Post Operative Pain | Dental Pulp NecrosesSaudi Arabia